Correlation Ventures

Formic raised $50M in growth capital, led by Mercato Partners, with debt financing from S2G Investments. Our robots already run inside 100+ manufacturing facilities across 30+ states, at 99.6% uptime with a 97% customer renewal rate. This capital scales that operating model into a commercialization platform for physical AI, so new robotic capabilities reach real factory floors instead of staying in the lab. Thank you to Mercato Partners, S2G Investments, @Light Ray Ventures, Lightscape Partners, Citi, Litquidity Ventures, our customers, and the team that keeps these systems running every shift. Read the release in Axios: https://lnkd.in/e_xATXxX

2026 has been a red-letter year for AiPrise. The company has grown powerfully over the past year and is showing no sign of slowing down. What is driving such stellar growth? According to Chaitanya Sarda, CEO at AiPrise , the key watchword for growth has been an increase in customers. Read the full interview here: https://lnkd.in/ergvFsyf Rushabh M. Shah Christopher Howie Orewa Jenny Olusanya Kavya Tiwari

Today Trust3 AI is bringing Agent DOS to Claude Code, giving security teams oversight of every Claude Code session and the data/tools/systems it reaches. “Agent DOS gives security complete oversight, so agent-written code ships under the same scrutiny,” says Balaji Ganesan, Co-founder and CEO of Trust3 AI. If Claude Code is in your stack, your AI security measures should reach it too. See the full press release in the comments. #ClaudeCode #AgentSecurity #AIGovernance

I left Apple to build healthcare that listens and acts early. Today, I'm excited to introduce UniqueHuman. We're building proactive healthcare agents that handle every step of care for people with chronic conditions. Our mission is to end chronic suffering. That means solving an illness from its root cause to what works for each person, before it drags on for years. That requires care that watches continuously, acts proactively, and learns from millions of people. Traditional healthcare can't deliver that because care is always capped by a doctor's time. UniqueHuman is building care that scales without limits. We're partnering with health institutions across the country, so your agent can manage end-to-end care in a HIPAA-secure infrastructure. We're backed by incredible investors and angels including Afore Capital, Correlation Ventures, Inuka Capital, Antler, Gaurav Jain, Anamitra Banerji, Wesley Barrow, Raj Sheth, Gautam Shewakramani, Nitin Sharma

Tomorrow. Meet your new teammate. Live at 1 PM ET. Registration link in comments.

Fora has been named one of LinkedIn’s Top Startups for 2026. What makes this recognition especially meaningful is how LinkedIn determines its rankings. Rather than relying on nominations or applications, the list is based on data measuring employee growth, engagement, interest from job seekers, and the ability to attract top talent. This is Fora’s second time on the U.S. list - we were #29 in 2024, back when we had just 70 HQ employees. It’s a testament to how far we’ve come in just a few short years, and to the incredible team we've built along the way. Travel advising has always been a serious profession. Our job is to build the platform that treats it like one: the tools, support, and community to grow a business at the highest level. Want to build it with us? We’re hiring → https://lnkd.in/dkdg54xX See the full 2026 list on LinkedIn News → https://lnkd.in/gcXtYa5d

Excited to share that Neura Health has partnered with Lumos Labs (Lumosity), the brain training app trusted by over 120 million registered users and used in more than 175 peer-reviewed research articles. Their short daily games are designed to exercise memory, attention, and problem solving, and now that science backed approach to brain training is connected to real neurology care. Lumosity users who want to see a cognitive neurologist can get referred directly to Neura Health in the Lumosity app, where they can connect with a board certified neurologist from home, no matter where they live. And our patients can access Lumosity at a 50% discount as another tool to support their cognitive health alongside their care, by visiting https://lnkd.in/e9Fub6pf Access to neurology care is one of the biggest gaps in healthcare today, especially outside major cities. Partnerships like this one help us reach more patients who need care and give people more ways to take an active role in their brain health, from the games they play to the doctors they see. If you or someone you know needs fast access to a high-quality neurologist, you can sign up with Neura Health here: https://lnkd.in/e_enBh8F Thank you to Bob Schafer for the partnership opportunity, and to everyone who helped bring this to life! #brainhealth #cognitive #neurology

Youth-focused sports digital media company Overtime has raised a strategic investment round led by Eldridge Capital Management 📈 The new investment is expected to support Overtime’s initiatives across content, commerce, technology and live sports properties, including Overtime Elite, Overtime Select and OT7. MORE: https://ow.ly/Sn2k50ZT37c

Today, Dr. Eike Gerhardt, Lawrence Callahan, and I are excited to announce our $11M seed round for Autopoiesis Sciences. Over the last year, we launched Aristotle, an AI research partner now used by thousands of researchers across institutions including Pfizer, the FDA, Harvard, GSK, Merck, MIT, AstraZeneca, Stanford, Johnson & Johnson, the NIH, Bristol-Myers Squibb, the European Medicines Agency, Oxford, Yale, and Johns Hopkins. We also pioneered Metacognitive Steering, a new inference-time control technique that reads a model's internal cognitive state and adjusts its layer-specific activations to guide how it reasons over a long investigation, helping it decide when to explore, challenge its assumptions, verify, or change direction, without modifying its underlying parameters. That work led to Columbus-1, our first autonomous research system for long-horizon scientific reasoning. Columbus-1 has already produced novel results across a growing set of scientific and engineering domains.   We’ve raised $11M in seed funding led by Threshold Ventures, with participation from Informed Ventures, Alpaca VC, VitalStage Ventures, Correlation Ventures, Darkmode Ventures, Mike Mahlkow, Cross Atlantic Angels, Max Keller, JD Montgomery, Adam Grosser, and others, to continue to build AI capable of autonomous scientific discovery. We have demonstrated tremendous capabilities despite significant constraints, and will continue to do so. I have surrendered my autonomy to become an instrument of this mission, so that your children can inherit a world free of disease and scarcity, and know they owe it to what we are building. If you want to do your life's work with us, please reach out. Lisa Xu Josh Stein Emily Melton Sunny Kumar, MD Aubrie Pagano Brian Shin Wesley Barrow Raphael Danilo Jens Weitzel Niklas Herriger Ally Warson Hiro Mizushima Vanessa Cann Tomás Ureña Muñoz